1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells
(2020) In Proceedings of the National Academy of Sciences of the United States of America 117(33). p.20127-20138
- Contribution to journal › Article
- 2019
-
Mark
The molecular landscape of ETMR at diagnosis and relapse
- Contribution to journal › Article
-
Mark
TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma
- Contribution to journal › Article
- 2017
-
Mark
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation
- Contribution to journal › Article
- 2016
-
Mark
Preoperative systemic levels of VEGFA, IL-7, IL-17A, and TNF-β delineate two distinct groups of children with brain tumors
- Contribution to journal › Article
-
Mark
Gain of 1q as a prognostic biomarker in Wilms Tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial : A SIOP renal tumours biology consortium study
- Contribution to journal › Article
- 2015
-
Mark
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
- Contribution to journal › Article
-
Mark
Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.
- Contribution to journal › Article
-
Mark
Multiple mechanisms of MYCN dysregulation in Wilms tumour.
- Contribution to journal › Article
- 2014
-
Mark
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
- Contribution to journal › Article
